Company news
Newbury Pharmaceuticals AB news in 2026
Newbury Pharmaceuticals AB's news releases, calls and decks from 2026, newest first.
Newbury Pharmaceuticals secures exclusive rights to a 40-product hospital portfolio in Iraq
September 28, 2026
Newbury Pharmaceuticals accelerates its neuroscience ambitions with a new partnership for Guanfacine tablets
August 17, 2026
Newbury Pharmaceuticals Secures Generic Approval for Tofacitinib Newbury
July 13, 2026
Newbury Pharmaceuticals Secures Generic Approval for Dalbavancin Newbury
July 10, 2026
Newbury Pharmaceuticals Secures Generic Approval for Palbociclib Newbury
April 17, 2026
Newbury Pharmaceuticals extends and increases loan agreement to SEK 30m, convenes EGM
March 26, 2026
Newbury Pharmaceuticals has entered into a new partnership for Prucalopride tablets
March 18, 2026
Newbury Pharmaceuticals Secures 12-Month Pazopanib Tender in Denmark
January 29, 2026